BCL2 and cancer: In vivo and in vitro experiments revealed that these active components significantly induced apoptosis in cancer cells, markedly reduced the expression of p-EGFR, HSP90, p-AKT, p-PI3K, and bcl-2, and increased the expression of ppar, bax, cleaved caspase 3, and cleaved PARP.